Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Carboplatin 89 Pemetrexed 65 Paclitaxel 50 Erlotinib Hydrochloride 46 Cisplatin 46 Radiotherapy 45 Docetaxel 37 Gemcitabine 34 Bevacizumab 32 pembrolizumab 25 Nivolumab 23 Radiosurgery 18 Etoposide 18 durvalumab 12 Cetuximab 12 Ipilimumab 11 Albumin-Bound Paclitaxel 10 Vinorelbine 9 Taxes 9 Gefitinib 9 Radiation 8 Magnetic Resonance Spectroscopy 8 osimertinib 7 Specimen Handling 7 Platinum 7 Cyclophosphamide 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 vandetanib 6 epacadostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡